Stocks
REGENXBIO Inc.RGNX
NASDAQHealthcareBiotechnology$8.57-5.62%
A clinical-stage biotechnology company developing gene therapies using adeno-associated virus (AAV) vectors. Its proprietary NAV Technology Platform is used both in internal drug programs targeting rare genetic diseases and through licensing agreements with pharmaceutical partners. Investors track t...
Market Cap: $442.3M52W Range: $5.04 – $16.19
Congressional Interest in REGENXBIO Inc. (RGNX)
2 members of Congress have disclosed 3 trades in REGENXBIO Inc. (RGNX), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
2
Buys
1
Sells
2
Who in Congress Is Trading RGNX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-12-20 | Anna Paulina Luna | sell | $15K – $50K |
| 2019-11-08 | PETER WELCH | sell | $1K – $15K |